Advances in local ablation therapy for liver cancer with portal hypertension
DOI:10.3969/j.issn.1001-5256.2021.03.005
- VernacularTitle:肝癌合并门静脉高压的局部消融治疗
- Author:
Wen LUO
1
;
Jun TIE
Author Information
1. Department of Ultrasound, Xijing Hospital, Air Force Medical University, Xi′an 710032, China
- Publication Type:Research Article
- Keywords:
Hepatocellular Carcinoma;
Hypertension, Portal;
Catheter Ablation
- From:
Journal of Clinical Hepatology
2021;37(3):515-521
- CountryChina
- Language:Chinese
-
Abstract:
With the comprehensive application of a variety of treatment methods, the survival time of patients with primary liver cancer is gradually increasing. For patients with early-stage liver cancer and portal hypertension, local ablation therapy can achieve long-term survival and play a positive role in stabilizing portal venous pressure, preserving liver function, and reducing complications. In addition, it can be combined with other techniques such as transarterial chemoembolization, transjugular intrahepatic portosystemic shunt, splenectomy, and pericardial devascularization to further improve treatment outcome. Several measures can be taken in the perioperative period to improve the management efficiency of patients after ablation, such as objective evaluation of portal venous pressure, prevention of esophagogastric variceal bleeding, correction of hypersplenism, prevention of postoperative liver failure, and multidisciplinary team management.
